Mark Glickman
Director/Board Member at NEUROBO PHARMACEUTICALS, INC.
Net worth: 8 824 $ as of 30/05/2024
Profile
Mark A.
Glickman is currently the President & Chief Executive Officer at BioFlorida, Inc. and an Independent Director at NeuroBo Pharmaceuticals, Inc. Previously, he served as the Co-CEO & Chief Business Officer at TherapeuticsMD, Inc. from 2021 to 2022.
He also held positions such as Marketing Director & Vice President-Sales at KOS Pharmaceuticals, Inc. from 2001 to 2007, General Manager-Sales at Baxter Healthcare Corp.
from 1989 to 1995, and Senior Vice President-Sales & Marketing at Oscient Pharmaceuticals Corp.
from 2007 to 2009.
Additionally, he was the Chief Commercial Officer at Esperion Therapeutics, Inc. from 2018 to 2020, Chief Commercial Officer at POZEN, Inc. in 2015, and Senior Vice President-Sales at Auxilium Pharmaceuticals LLC from 2012 to 2015.
He also held the position of Vice President-Sales at Bayer HealthCare.
Furthermore, he served as the Vice President-Medical Device Division at Otsuka America Pharmaceutical, Inc. from 2009 to 2012 and Chief Commercial Officer at Old API Wind-down Ltd.
from 2015 to 2018.
Mr. Glickman obtained an undergraduate degree from the State University of New York College at Oswego and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/06/2024 | 1,562 ( 0.03% ) | 5 951 $ | 30/05/2024 | |
THERAPEUTICSMD, INC.
0.01% | 05/12/2022 | 1,294 ( 0.01% ) | 2 873 $ | 30/05/2024 |
Mark Glickman active positions
| Companies | Position | Start |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Director/Board Member | 10/05/2023 |
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Chief Executive Officer | 08/12/2023 |
Former positions of Mark Glickman
| Companies | Position | End |
|---|---|---|
| THERAPEUTICSMD, INC. | Chief Executive Officer | 29/12/2022 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 10/12/2020 |
| OLD API WIND-DOWN LTD. | Corporate Officer/Principal | 29/03/2018 |
| POZEN INC. | Corporate Officer/Principal | 31/01/2016 |
| AUXILIUM PHARMACEUTICALS, INC. | Sales & Marketing | 28/02/2015 |
Training of Mark Glickman
| State University of New York College at Oswego | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| THERAPEUTICSMD, INC. | Health Technology |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
| Bayer HealthCare /Diabetes Care Division/ | Distribution Services |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Inc. engages in the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the following geographical segments: United States and Canada. The company is founded on December 2, 2015, and is headquartered in Mississauga, Canada. | Health Technology |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013. | Commercial Services |
- Stock Market
- Insiders
- Mark Glickman
